Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML.
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML. Drug Resist Updat. 2009 Jun; 12(3):81-9.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Drug Resistance, Neoplasm
fms-Like Tyrosine Kinase 3
Humans
Leukemia, Myeloid, Acute
Models, Biological
Molecular Structure
authors with profiles
James Douglas Griffin, M.D.
Nathanael Gray, Ph.D.
Ellen L. Weisberg, Ph.D.
Richard M. Stone, M.D.